Primary palmar hyperhidrosis
Conditions
Interventions
The service lasted twenty minutes, three times a week for four weeks. Participants were assessed before treatment and reassessed in the sixth and final sessions, and three days, two weeks, four and si
Other
Sponsors
Universidade Católica do Salvador
Universidade Católica do Salvador
Eligibility
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Individuals of both sexes who had bilateral primary palmar hyperhidrosis
Exclusion criteria
Exclusion criteria: Individuals presenting metallic implants in the upper limbs, impaired sensation in the hands of, who used drugs that caused the malfunction, or perform some other type of treatment for hyperhidrosis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Iontophoresis as a therapeutic resource features in the short term, significant results in the treatment of primary palmar hyperhidrosis, providing patients with an improvement in their quality of life by reducing excessive sweating in the affected area in a non-invasive and without developing intolerance. Patient evaluation was performed by the application of two questionnaires. The first was the Quality of Life Questionnaire in Patients with hyperhidrosis,in which 20 points representing "excellent" and 100 "very bad". The other scale used was the Questionnaire for Disorders of the Shoulder, Arm and Hand (DASH), in which 30 points represent a minimal impairment, and 150, maximum dysfunction. The Minor test was used to identify and quantify the areas hyperhidrotic. The reaction between iodine solution (2%) and corn starch was recorded by a digital photography (camera Samsung - Digimax A 503), to monitor the progress of treatment. Areas with hyperhidrosis have been classified as an area - only involvement fingertips, area 2 - proximal and middle phalanges, area 3 - the lower half of the palm, area 4 - the top half of the palm. Both the questionnaires and the Minor test were performed on all revaluations. | — |
Secondary
| Measure | Time frame |
|---|---|
| Temporary reduction in sweating in other body regions, according to the testimony of the patients. | — |
Countries
Brazil
Contacts
Public ContactRebeca Cruz
Universidade Católica do Salvador
Outcome results
None listed